Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination (Q77639628)
scientific article published on 01 February 2002
Language:
(P31) (Q13442814)
(P304) 1000-1007
(P407) (Q1860)
(P433) 4
(P478) 20
(P577) Friday, February 1, 2002
(P921) (Q107129060)
(P1433) (Q400292)
(P1476) "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" (language: en)
(P2093) Nadia Harbeck
Ronald E Kates
Manfred Schmitt
other details
description scientific article published on 01 February 2002

External Links